Units of Dental Activity, the NHS payment system, do not adequately reward dentists. Perhaps it’s time to recognise that not all dentists working in the NHS should be expected to carry out root canal treatments without additional funding. After all, even for the best of us a complex ...
TEETH WHITENING The perfect smile for video calls Smile, you’re on camera! If your day is filled with teleconferences or online classes... Read More TEETH WHITENING Whitening toothpaste - hydrogen peroxide vs. carbamide peroxide If you lose one or more of your front teeth due t...
Risk factors for Lung Cancer: Dental / Oral Periodontal Disease - Gingivitis January, 2018: A study published in the Journal of the National Cancer Institute found that those with severe gum disease were at significantly higher risk of developing various cancers. Those with severe gum disease wer...
and 6) Pharmacological treatment of PKU. They searched for relevant literature in PubMed (MEDLINE), EMBASE, NHS Economic Evaluations Database and The Cochrane Library being helped by the project assistant. For some subjects, additional search systems were used and reference lists were checked. All...
treatment for patients with unresectable stage III disease is concurrent chemoradiotherapy (cCRT); however, only recently, the combination with ICI has been explored. The Phase 3 PACIFIC study randomised 713 patients with confirmed locally advanced, unresectable, stage III NSCLC, whose disease has not...
cardiovascular disease,19a known comorbidity for depression, so their use in depression may be problematic. Besides, many trials of anti-inflammatory drugs for depression are based on people with chronic physical illness16but it is unclear whether the improvement in depression is due to the ...
“Wouldn’t it be mad, for the NHS to spend so much on me, for me to walk out the door, pick up COVID and die tomorrow sort of thing, that’s the thing! [they said] ‘Look, your situation is that your IV Ig and IgG levels are still zero. So, from a B cell perspective, ...
The present invention relates to non-viral gene therapy methods and compositions for treatment of hyperproliferative disease in humans. More specifically, the invention is directed,
The individual may have a family history of early cardiovascular disease—for example, having a father or brother that developed heart disease or had a heart attack or stroke before the age of 55, or a mother or sister that had such a condition before the age of 65. The individual may be...
The present invention includes a pharmaceutical composition comprising HDV insulin or oral HDV insulin, and one or more additional therapeutic agents useful for the treatment of diabetes and diabetes related ailments. The present invention also includes a method of making the pharmaceutical inventions of...